Dragan Y P, Xu Y H, Pitot H C
Department of Oncology, McArdle Laboratory for Cancer Research Medical School, University of Wisconsin, Madison 53706.
Carcinogenesis. 1993 Mar;14(3):385-91. doi: 10.1093/carcin/14.3.385.
The dose-response characteristics of initiation of hepatocarcinogenesis by diethylnitrosamine (DEN) was investigated in the neonatal female rat by means of the quantitative stereologic estimation of altered hepatic foci (AHF) expressing multiple markers. At 5 days of age, female Sprague-Dawley rats were given a single i.p. dose of DEN (0.1-30 mg/kg body wt) or the vehicle (trioctanoin). The semisynthetic AIN-76A diet was provided to half of the rats in each treatment group, while the remainder received this diet containing 500 mg phenobarbital (PB)/kg for 8 months from weaning until the animals were killed. To ascertain more exactly the dose-response relationship for initiation by DEN, the number, volume percentage and phenotypes of the resulting AHF were determined by quantitative stereological analysis on serial sections of frozen tissue, each stained for one of four markers of preneoplasia. A linear relationship was observed between the dose of DEN (0-30 mg/kg) and the number and volume percentage of AHF detected, with each single marker or the total number of AHF detected when the placental isozyme of glutathione S transferase, gamma-glutamyl transpeptidase (GGT), canalicular adenosine triphosphatase, or glucose-6-phosphatase was used as the marker. For each dose, PB administration increased the number and volume of AHF scored compared with similarly initiated rats that did not receive a promoting stimulus. This was, in part, owing to enhanced GGT expression in AHF with PB administration. Promotion by PB resulted in a distribution of AHF phenotypes altered from that observed in rats not receiving PB. Initiation of AHF in neonatal female rats by DEN was linear with doses from 0 to 30 mg/kg for all four of the phenotypic markers employed. In addition, while PB administration stimulated the growth of all AHF phenotypes, the growth of a subset of AHF that expressed the widest variation in preneoplastic markers was specifically enhanced by PB administration.
通过对表达多种标志物的肝脏病变灶(AHF)进行定量立体学评估,研究了新生雌性大鼠中二乙基亚硝胺(DEN)引发肝癌发生的剂量反应特征。5日龄时,给雌性Sprague-Dawley大鼠腹腔注射单次剂量的DEN(0.1 - 30 mg/kg体重)或溶剂(三辛酸甘油酯)。每个处理组的一半大鼠给予半合成的AIN - 76A饲料,其余大鼠从断奶至处死期间的8个月内接受含500 mg苯巴比妥(PB)/kg的该饲料。为更准确地确定DEN引发的剂量反应关系,通过对冷冻组织连续切片进行定量立体学分析,确定所得AHF的数量、体积百分比和表型,每个切片针对四种癌前标志物之一进行染色。当使用谷胱甘肽S转移酶胎盘同工酶、γ-谷氨酰转肽酶(GGT)、胆小管三磷酸腺苷酶或葡萄糖-6-磷酸酶作为标志物时,观察到DEN剂量(0 - 30 mg/kg)与检测到的AHF数量和体积百分比之间呈线性关系。对于每个剂量,与未接受促癌刺激的类似引发的大鼠相比,给予PB增加了评分的AHF数量和体积。这部分是由于给予PB后AHF中GGT表达增强。PB的促癌作用导致AHF表型分布与未接受PB的大鼠中观察到的不同。对于所采用的所有四种表型标志物,新生雌性大鼠中DEN引发AHF的剂量在0至30 mg/kg范围内呈线性关系。此外,虽然给予PB刺激了所有AHF表型的生长,但给予PB特异性增强了表达癌前标志物变化最广泛的一部分AHF的生长。